S 2398119th CongressIntroduced

Kay Hagan Tick Reauthorization Act

Introduced: Jul 23, 2025

Sponsor: Sen. Collins, Susan M. [R-ME] (R-Maine)

Healthcare

Standard Summary

Comprehensive overview in 1-2 paragraphs

The Kay Hagan Tick Reauthorization Act reauthorizes key U.S. government programs that address tick-borne and vector-borne diseases. Specifically, it extends the authorities for support related to a National Strategy and Regional Centers of Excellence in Vector-Borne Diseases, and for enhanced assistance to health departments addressing vector-borne diseases. The reauthorization shifts the active period for these programs from 2021–2025 to 2026–2030, and updates how the programs operate and who is involved in implementing them. In short, the bill aims to keep federal efforts focused on tick-related disease prevention, surveillance, and public health support through 2030, with some administrative changes to participation and leadership.

Key Points

1Reauthorizes two major programs:
2- National Strategy and Regional Centers of Excellence in Vector-Borne Diseases.
3- Enhanced support to assist health departments in addressing vector-borne diseases.
4Authorization period extended from 2021–2025 to 2026–2030 for both programs.
5Governance changes:
6- Replaces explicit reference to the Tick-Borne Disease Working Group with language referring to “appropriate individuals.”
7- Changes the coordination language from “in coordination with” to “acting through.”
8The short title is the Kay Hagan Tick Reauthorization Act.
9The amendments apply to sections of the Public Health Service Act (notably 317U and 2822(c)) to implement the reauthorization and updated governance.

Impact Areas

Primary group/area affected:- State and local health departments, and public health agencies, that participate in or benefit from vector-borne disease programs; tick-borne disease researchers and public health professionals; communities affected by tick-borne diseases.Secondary group/area affected:- Federal programs and agencies administering the Public Health Service Act authorities related to vector-borne diseases; policymakers and federal officials overseeing disease prevention and surveillance.Additional impacts:- Provides continued federal support for tick- and vector-borne disease efforts through 2030, with updated leadership/participation language that could affect how programs are organized or who directs them.- May influence funding planning, interagency collaboration, and program administration by clarifying who can lead or act on behalf of the initiatives.

Generated by gpt-5-nano on Oct 8, 2025